HYPD

Hyperion DeFi, Inc., headquartered in New York, is an avant-garde technology firm poised to transform ophthalmic healthcare through its innovative solutions. The company excels in the development and commercialization of state-of-the-art products that enhance eye care and significantly improve patient outcomes. By harnessing the latest advancements in ophthalmology, Hyperion DeFi seeks to address pressing market needs while ambitiously broadening its presence within the U.S. healthcare sector. With a steadfast commitment to innovation and strategic growth initiatives, the company is well-positioned to leverage emerging opportunities in the rapidly evolving eye care landscape.